Amyloid PET in the diagnostic workup of neurodegenerative disease

Several radiotracers have been employed to bind amyloid plaques in the brain for the differential diagnosis of neurodegenerative disease, open the possibility to measure in vivo pathogenic processes implicated in Alzheimer disease (AD) and have the potential to detect disease processes at the earliest stages with a potential role in clinical trials’ longitudinal assessment. Visual reading is clinically adequate in clearly positive or negative...